A recent study from the Department of Cardiology and Pneumology, Charité University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin 12200, Germany shows that “Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury.” This study was published in the 1 August’13 issue of the Journal “Cardiovascular Research” by Prof. Skurk C., Dr. Jenke A and others.
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Turning off inflammation inhibits autoimmune myocarditis: Rhamnetin, an O-methylated flavonol isolated from cloves, inhibits cardiac inflammation and injury via down regulation of its target gene. Thus, pharmacological formulations encompassing “Rhamnetin or its analogues” may be used to treat patients suffering from autoimmune myocarditis.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Turning off inflammation inhibits autoimmune myocarditis: Rhamnetin, an O-methylated flavonol isolated from cloves, inhibits cardiac inflammation and injury via down regulation of its target gene, 19/March/2015, 22.19, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Undisclosed information: How Rhamnetin suppresses cardiac inflammation and injury
* Research cooperation
